摘要
结直肠癌是世界上最常见的恶性肿瘤之一,居恶性肿瘤发病率的第3位。西方化生活方式和饮食习惯使中国结直肠癌的发病率呈逐年上升的趋势,且40岁以下年轻人占30%以上,因此。在中国关注结直肠癌、尤其低位直肠癌的治疗状况非常有意义。尽管手术切除仍是直肠癌最重要的治疗手段,但淋巴结阳性和肿瘤侵犯浆膜者很容易发生肝、肺等远处转移,其局部复发率也很高;晚期患者的局部复发率为4%~40%,
出处
《中华胃肠外科杂志》
CAS
2007年第4期396-398,共3页
Chinese Journal of Gastrointestinal Surgery
参考文献21
-
1Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol, 2001:533-543.
-
2You W, Jin F, Gridley G, et al. Trends in colorectal cancer rates in urban Shanghai, 1972-1996, in relation to dietary changes. Ann Epidemiol, 2000, 10:469.
-
3Zhang YL, Zhang ZS, Wu BP, et al. Early diagnosis for colorectal cancer in China. World J Gastroenterol, 2002,8 : 21- 25.
-
4Abulafi AM, Williams NS. Local recurrence of colorectal cancer :The problem, mechanisms, management and adjuvant therapy. Br J Surg, 1994,81:7-19.
-
5邓艳红,詹文华.结直肠癌新辅助治疗的新进展[J].中国实用外科杂志,2005,25(5):310-312. 被引量:21
-
6Jones B, Dale RG. The potential for mathematical modeling in the assessment of the radiation dose equivalent of eytotoxie chemotherapy given concomitantly with radiotherapy. Br J Radiol, 2005,78 : 939-944.
-
7Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in respectable rectal cancer. N Engl J Med, 2002, 33 : 980-987.
-
8NIH consensus conference : adjuvant therapy for patients withcolon and rectal cancer. JAMA, 1990,264 : 1444-1450.
-
9Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med, 2004,351 : 1731-1740.
-
10Rich TA, Shepard RC, Mosley ST. Four decades of continuing innovation with fluorouracil: Current and future approaches to fluorouracil chemoradiation therapy. J Clin Oncol, 2004,22 : 2214-2232.
二级参考文献39
-
1郁宝铭,吴唯勤.新辅助化放疗与TME联合治疗局部进展期低位直肠癌[J].中国实用外科杂志,2005,25(5):270-272. 被引量:56
-
2Chau I,Chan S,Cunningham D.Overview of preoperative and postoperative therapy for colorectal cancer:the European and United States perspectives.Clin Colorectal Cancer,2003,3(1):19-33.
-
3Schuhmacher C,Fink U,Siewert JR.Preoperative downstaging in advanced stomach carcinoma.Wishful thinking or reality.Zentralbl Chir,2000,125(4):333-334.
-
4Niederhuber JE.Neoadjuvant therapy.Ann Surg,1999,229(3):309-312.
-
5Geh JI,Glynne Jones R,Kwok QS,et al.Preoperative ECF chemotherapy in gastro-oesophageal adenocarcinoma.Clin Oncol,2000,12(3):182-187.
-
6Rustum YM,Harstrick A,Cao S,et al.Thymidylate synthase inhibitors in cancer therapy:direct and indirect inhibitors.J Clin Oncol,1997,15(1):389-400.
-
7Andre T,Louvet C,de Gramont A.Colon cancer: what is new in 2004?Bull Cancer,2004,91(1):75-80.
-
8Frena A,Martin F,La Guardia G,et al.Liver resection after downstaging with neoadjuvant chemotherapy for "unresectable" colorectal metastases.Chir Ital,2004,56(3):351-357.
-
9Ong SY.Neoadjuvant chemotherapy in the management of colorectal metastases:A review of the literature.Ann Acad Med Singapore,2003,32(2):205-211.
-
10Bathe OF,Dowden S,Sutherland F,et al.Phase Ⅱ study of neoadjuvant 5-FU+leucovorin+CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma.BMC Cancer,2004,4(1):32.
共引文献23
-
1汪晓东,高强,吕东昊,吴俊华,李臻辉,李立.64排螺旋CT联合血清淀粉样蛋白A对直肠下段癌术前分期的临床价值[J].肿瘤学杂志,2009,15(10):893-897.
-
2宋新明.新辅助治疗在低位进展期直肠癌中的应用[J].消化肿瘤杂志(电子版),2010,2(4):200-202. 被引量:2
-
3范敏,唐宗江.低位直肠癌新辅助治疗的研究进展[J].结直肠肛门外科,2006,12(2):122-124. 被引量:5
-
4陈益民,毛江平,罗庆伟,李盛,张虎生.5-Fu肠腔化疗辅助结直肠癌根治术的应用及其机制探讨[J].鄂州大学学报,2006,13(6):43-45. 被引量:2
-
5张忠国,王辉,宋纯.结直肠癌肝转移患者预后因素分析[J].中国肿瘤临床,2007,34(14):815-818. 被引量:9
-
6李天煜,陈博艺,程军,高翔,邓国荣,许建德,李冲,陈恩碧,郑慧琼.术前区域化疗联合放疗对低位直肠癌术后复发及P53表达的影响[J].岭南现代临床外科,2007,7(4):250-252.
-
7李天煜,陈利生,陈博艺,程军,高翔,邓国荣,许建德,李冲,陈恩碧,郑慧琼.区域化疗联合放疗对低位直肠癌术后p53表达及细胞凋亡的影响[J].临床外科杂志,2007,15(11):765-766.
-
8唐宗江,郭云,唐卫中.术前放化疗对低位直肠癌患者细胞免疫功能及保肛的影响[J].结直肠肛门外科,2007,13(3):150-152. 被引量:6
-
9汪建平,丁卫星,邓艳红,兰平,潘凯,董功航,邓建中,王磊,吴小剑,郭学锋,郑洁.FOLFOX方案联合放疗的新辅助治疗在低位直肠癌中的临床多中心研究[J].中华胃肠外科杂志,2008,11(2):116-119. 被引量:19
-
10兰平,董功航.中低位直肠癌的新辅助放化疗的进展及存在的问题[J].岭南现代临床外科,2008,8(2):83-84. 被引量:3
同被引文献54
-
1黄彦钦,袁瑛,王亚平,朱明,张苏展,郑树.中国人遗传性非息肉病性结直肠癌错配修复基因大片段缺失研究[J].中华医学遗传学杂志,2005,22(1):88-90. 被引量:5
-
2邓艳红,詹文华.结直肠癌新辅助治疗的新进展[J].中国实用外科杂志,2005,25(5):310-312. 被引量:21
-
3徐宗斌,林惠铭,池畔.腹腔镜与开腹中低位直肠癌保肛手术后并发症的比较[J].肿瘤学杂志,2006,12(1):50-53. 被引量:9
-
4Lam CW, Chen WT, Liu Mr, et al. Effect of preoperative concurrent chemoradiotherapy in locally advanced low rectal cancer after radical resection surgery. Int Surg, 2005,90:53-59.
-
5Karakiewicz PI, Trlnh QD, de la Taille A, et al. ECOG performance status 0 or 1 and symptom classification do not improve the ability to predict renal cell carcinoma-speclfic survival. Eur J Cancer, 2007,43 : 1023-1029.
-
6Frei E.3rd. Clinical cancer research: an embattled species. Cancer, 1982,50 : 1979-1992.
-
7Wilke H, Preusser P, Fink U, et al. Preoperative chemotherapy in locally advanced and nonresectable gastric cancer:a phase Ⅱ study with etoposide,doxorubicin,and eisplatin. J Clin Oncol, 1989,7:1318-1326.
-
8Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med, 2004, 351 : 1731-1740.
-
9Gerard JP, Chapet O, Nemoz C, et al. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase Ⅱ trial. J Clin Oncol, 2003,21:1119- 1124.
-
10Fakih MG, Rajput A, Yang GY, et al. A phase I study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma. Int J Radiat Oncol Biol Phys, 2006,65 : 1462-1470.
引证文献4
-
1汪建平,丁卫星,邓艳红,兰平,潘凯,董功航,邓建中,王磊,吴小剑,郭学锋,郑洁.FOLFOX方案联合放疗的新辅助治疗在低位直肠癌中的临床多中心研究[J].中华胃肠外科杂志,2008,11(2):116-119. 被引量:19
-
2邓艳红,黄美近,汪建平,林桐榆,肖健,蔡永华,LIN,Edward-H.5氟尿嘧啶上调干细胞标记物CD133在结肠癌细胞中的表达[J].中国病理生理杂志,2009,25(11):2187-2191. 被引量:10
-
3张鑫,李耀平,冯毅.中低位进展期直肠癌患者新辅助化放疗后肿瘤分期及生物学特性的改变[J].中华临床医师杂志(电子版),2013,7(19):37-40. 被引量:5
-
4吴丽媛,李偲,彭锐,龚舒,徐柳,邹方东.miR-21介导的结肠癌细胞对5-氟尿嘧啶的耐药机制研究[J].中华医学遗传学杂志,2015,32(5):620-624. 被引量:9
二级引证文献43
-
1董功航,汪建平,邓艳红,丁卫星,兰平.术前经新辅助治疗的中低位直肠癌患者吻合口漏的预防和治疗[J].中华普通外科杂志,2009,24(2):100-102. 被引量:12
-
2汪建平.中国直肠癌治疗现状与思考[J].中华胃肠外科杂志,2009,12(3):211-214. 被引量:17
-
3吴斌,肖毅,林国乐,张福泉,胡克,邱辉忠.术前应用FOLFOX方案联合放疗治疗中低位直肠癌35例报告[J].癌症进展,2009,7(3):263-266. 被引量:1
-
4郭兢津,梁伟雄,张彤.腹腔镜与开腹手术治疗结肠癌、直肠癌的远期疗效观察[J].实用临床医药杂志,2010,14(5):104-104. 被引量:34
-
5Yan-Hong Deng,Xing-Xiang Pu,Mei-Jin Huang,Jian Xiao,Jia-Ming Zhou,Tong-Yu Lin,Edward H. Lin.5-Fluorouracil upregulates the activity of Wnt signaling pathway in CD133-positive colon cancer stem-like cells[J].Chinese Journal of Cancer,2010,29(9):810-815. 被引量:4
-
6周毅,华扬,王涛,陈硕,王凤伟,王为忠,张锡朋.术后同步放化疗在Ⅲ期低位直肠癌中的应用价值[J].中华胃肠外科杂志,2010,13(10):748-750. 被引量:6
-
7冯觉平,林梅,袁响林,王亚萍,方静,李敏.5-氟尿嘧啶改变胰岛β细胞的超微结构并抑制胰岛素的释放[J].中国病理生理杂志,2011,27(1):119-123. 被引量:2
-
8戚国成,曹东,代果.结肠癌患者术中植入缓释型氟尿嘧啶的临床评估[J].现代医药卫生,2011,27(14):2101-2103. 被引量:1
-
9陈文晟,马磊,胡晓晔,刘晓燕,金川,李志彪,李卫东.大肠癌细胞中Oct4与CD133的表达及意义[J].南方医科大学学报,2011,31(8):1434-1436. 被引量:4
-
10蔡群榕,王小东.直肠癌术前三维适形放疗配合草酸铂联合亚叶酸钙和氟尿嘧啶同步化疗的临床观察[J].福建医科大学学报,2011,45(5):377-380. 被引量:4
-
1徐光炜.大肠癌患者的自我生活调节[J].癌症康复,2010(1):12-13.
-
2裴文仲,张湘茹,黄希芬,闫树旭.153例乳腺癌治疗状况调查报告[J].中国肿瘤,2000,9(1):35-36. 被引量:11
-
3王晓春,李中,于炳旗,刘现义.分化型甲状腺癌再次手术情况临床分析[J].河北医药,2013,35(10):1531-1532.
-
4刘宝善.直肠癌施行保留肛门括约肌功能手术的理论基础[J].中国实用外科杂志,1999,19(6):376-377. 被引量:55
-
5姚元庆.肿瘤患者生育功能保护的研究现状[J].解放军医学院学报,2013,34(8):797-798.
-
6梁寒,Pommer,S.瑞士圣加仑州立医院外科大肠癌治疗状况(附183例临床病理分析)[J].中国肿瘤临床,1996,23(3):198-203.
-
7刘金丹(编译).对宫颈癌治疗状况的一项评价[J].继续医学教育,2005,19(5):48-48.
-
8倪红斌,梁维邦,徐武,韦永祥,蒋健,陈杰,戴艳红,高下.神经电生理监测在显微切除听神经瘤术中面听神经保护的意义[J].中国微创外科杂志,2008,8(5):448-450. 被引量:10
-
9黄志强.胰腺癌外科近况[J].中华腔镜外科杂志(电子版),2012,5(1):1-4. 被引量:6
-
10李畅波,黄国武,张春.老年食管癌患者围手术期心肺功能保护探讨(附22例报告)[J].国际医药卫生导报,2011,17(13):1557-1559. 被引量:2